-transparent.png){kind=logo}
Renal infarction is an uncommon condition that resulted from inadequate perfusion of the kidney and is easily missed diagnosed due to its nonspecific clinical presentations. Major risk factors for renal infarction are atrial fibrillation, previous embolism, and ischemic and valvular heart disease. Progressive decrease in renal function or even death can occur if renal infarction is not diagnosed accurately and promptly. Ketamine abuse may cause variable urinary tract injury. However, renal infarction caused by ketamine abuse has never been reported. To our knowledge, this is the first documented case of renal infarction following nasal insufflation of ketamine.
Related Publications
Chin-Li Chen, and
Jin-Li Chen, and
Tai-Lung Cha, and
Sheng-Tang Wu, and
Shou-Hung Tang, and
Chih-Wei Tsao, and
En Meng
January 1980,
Urologic radiology,
Chin-Li Chen, and
Jin-Li Chen, and
Tai-Lung Cha, and
Sheng-Tang Wu, and
Shou-Hung Tang, and
Chih-Wei Tsao, and
En Meng
January 1985,
Rays,
Chin-Li Chen, and
Jin-Li Chen, and
Tai-Lung Cha, and
Sheng-Tang Wu, and
Shou-Hung Tang, and
Chih-Wei Tsao, and
En Meng
August 2013,
Hepatology (Baltimore, Md.),
Chin-Li Chen, and
Jin-Li Chen, and
Tai-Lung Cha, and
Sheng-Tang Wu, and
Shou-Hung Tang, and
Chih-Wei Tsao, and
En Meng
March 2001,
The Journal of urology,
Chin-Li Chen, and
Jin-Li Chen, and
Tai-Lung Cha, and
Sheng-Tang Wu, and
Shou-Hung Tang, and
Chih-Wei Tsao, and
En Meng
November 2017,
BMJ case reports,
Chin-Li Chen, and
Jin-Li Chen, and
Tai-Lung Cha, and
Sheng-Tang Wu, and
Shou-Hung Tang, and
Chih-Wei Tsao, and
En Meng
January 2012,
American journal of cardiovascular disease,
Chin-Li Chen, and
Jin-Li Chen, and
Tai-Lung Cha, and
Sheng-Tang Wu, and
Shou-Hung Tang, and
Chih-Wei Tsao, and
En Meng
February 2019,
Cureus,
Chin-Li Chen, and
Jin-Li Chen, and
Tai-Lung Cha, and
Sheng-Tang Wu, and
Shou-Hung Tang, and
Chih-Wei Tsao, and
En Meng
October 1999,
American journal of kidney diseases : the official journal of the National Kidney Foundation,
Chin-Li Chen, and
Jin-Li Chen, and
Tai-Lung Cha, and
Sheng-Tang Wu, and
Shou-Hung Tang, and
Chih-Wei Tsao, and
En Meng
September 1979,
FDA drug bulletin,
Chin-Li Chen, and
Jin-Li Chen, and
Tai-Lung Cha, and
Sheng-Tang Wu, and
Shou-Hung Tang, and
Chih-Wei Tsao, and
En Meng
July 1995,
The American journal of emergency medicine,
